These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 27600019)
1. [Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain]. Liu P; Zhang W; Zhang S; Zhang Y; Wang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 41(8):879-84. PubMed ID: 27600019 [TBL] [Abstract][Full Text] [Related]
2. Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. Hossain MZ; Ando H; Unno S; Kitagawa J Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093166 [TBL] [Abstract][Full Text] [Related]
3. The pharmacology of cannabinoid receptors and their ligands: an overview. Pertwee RG Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099 [TBL] [Abstract][Full Text] [Related]
4. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920 [TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778 [TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors. Desroches J; Charron S; Bouchard JF; Beaulieu P Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808 [TBL] [Abstract][Full Text] [Related]
7. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541 [TBL] [Abstract][Full Text] [Related]
8. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats. Chen L; Zhang J; Li F; Qiu Y; Wang L; Li YH; Shi J; Pan HL; Li M J Pain; 2009 Jul; 10(7):732-9. PubMed ID: 19409856 [TBL] [Abstract][Full Text] [Related]
9. Targeting the cannabinoid system for pain relief? Chiou LC; Hu SS; Ho YC Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672 [TBL] [Abstract][Full Text] [Related]
10. Role of the endocannabinoid system in a mouse model of Fragile X undergoing neuropathic pain. Ramírez-López A; Pastor A; de la Torre R; La Porta C; Ozaita A; Cabañero D; Maldonado R Eur J Pain; 2021 Jul; 25(6):1316-1328. PubMed ID: 33619843 [TBL] [Abstract][Full Text] [Related]
11. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain. Deng L; Cornett BL; Mackie K; Hohmann AG Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells. Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268 [TBL] [Abstract][Full Text] [Related]
14. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Jayamanne A; Greenwood R; Mitchell VA; Aslan S; Piomelli D; Vaughan CW Br J Pharmacol; 2006 Feb; 147(3):281-8. PubMed ID: 16331291 [TBL] [Abstract][Full Text] [Related]
15. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798 [TBL] [Abstract][Full Text] [Related]
16. [The cannabinoid system and pain: towards new drugs?]. Beltramo M J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815 [TBL] [Abstract][Full Text] [Related]
17. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Petrosino S; Di Marzo V Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159 [TBL] [Abstract][Full Text] [Related]
18. The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697 [TBL] [Abstract][Full Text] [Related]
19. Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B. Dai E; Zhang L; Ye L; Wan S; Feng L; Qi Q; Yao F; Li Z Int J Infect Dis; 2017 Jun; 59():124-130. PubMed ID: 28315398 [TBL] [Abstract][Full Text] [Related]
20. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction. Hutch CR; Hillard CJ; Jia C; Hegg CC Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]